Notably, one patient, KIT-5, had a long survival for more than 3 years from the onset of esophageal cancer, and marked immune spreading to NY-ESO-1 was induced during CHP-MAGE-A4 vaccination. The gene discussed is MAGEA4; the disease is esophageal cancer.